Last reviewed · How we verify

NCT04737733

Effects of a Dementia-friendly Program

Completed NA Last updated 4 February 2021
What this trial tests

NA trial testing The dementia friendly program in Delirium in 423 participants. Completed in 16 June 2020.

Timeline
22 November 2018
Primary endpoint
30 March 2020
16 June 2020

Quick facts

Lead sponsorUniversity Hospital, Akershus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment423
Start date22 November 2018
Primary completion30 March 2020
Estimated completion16 June 2020
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Akershus

Who can join

75 and older, any sex, with Delirium or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Frail older persons with cognitive impairment are at special risk of experiencing delirium during acute hospitalisation. The purpose of this study was to investigate whether a dementia-friendly hospital program contributes to improved detection and management of patients with cognitive impairment and delirium.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Impact of a dementia-friendly program on detection and management of patients with cognitive impairment and delirium in acute-care hospital units: a controlled clinical trial design.
    Weldingh NM, Mellingsæter MR, Hegna BW, Benth JS, et al · · 2022 · cited 10× · PMID 35361136 · DOI 10.1186/s12877-022-02949-0
  2. Impact of a Dementia-friendly Program on Detection and Management of Patients with Cognitive Impairment and Delirium in Acute-care Hospital Units: A Controlled Clinical Trial Design
    Weldingh NM, Mellingsæter MR, Hegna BW, Benth JŠ, et al · · 2021 · DOI 10.21203/rs.3.rs-206980/v2

Verify or expand the search:

Other recruiting trials for Delirium

Currently open trials in the same condition.

Other University Hospital, Akershus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04737733.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing